Author's reply to Wolstenholme and Sanfilippo and colleagues.
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Jennifer K
JK
Quint
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D029424:Pulmonary Disease, Chronic Obstructive / Q000401:mortality*; D012042:Registries
D000319:Adrenergic beta-Antagonists